Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: The comparison of Efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Seo, Jae-Bin | - |
dc.contributor.author | Kang, Si-Hyuck | - |
dc.contributor.author | Hur, Seung-Ho | - |
dc.contributor.author | Park, Kyung Woo | - |
dc.contributor.author | Youn, Tae-Jin | - |
dc.contributor.author | Park, Jong-Seon | - |
dc.contributor.author | Yang, Han-Mo | - |
dc.contributor.author | Lee, Hae-Young | - |
dc.contributor.author | Kang, Hyun-Jae | - |
dc.contributor.author | Koo, Bon-Kwon | - |
dc.contributor.author | Bae, Jang-Ho | - |
dc.contributor.author | Kim, Sang-Wook | - |
dc.contributor.author | Moon, Keon-Woong | - |
dc.contributor.author | Choi, Jae-Woong | - |
dc.contributor.author | Lee, Sang-Gon | - |
dc.contributor.author | Chung, Woo-Young | - |
dc.contributor.author | Kim, Soo-Joong | - |
dc.contributor.author | Kim, Doo-Il | - |
dc.contributor.author | Kim, Byung-Ok | - |
dc.contributor.author | Hyon, Min-Su | - |
dc.contributor.author | Park, Keum-Soo | - |
dc.contributor.author | Cha, Tae-Joon | - |
dc.contributor.author | Yoo, Chul-Woong | - |
dc.contributor.author | Jeon, Hui-Kyung | - |
dc.contributor.author | Kim, Hyo-Soo | - |
dc.date.available | 2019-03-09T01:58:51Z | - |
dc.date.issued | 2013-05 | - |
dc.identifier.issn | 0002-8703 | - |
dc.identifier.issn | 1097-5330 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/14677 | - |
dc.description.abstract | Aims Paclitaxel-eluting stents (PESs) have been shown to inhibit neointimal hyperplasia after percutaneous coronary intervention. Coroflex Please (B Braun, Melsungen, Germany) is a newly developed PES. We compared the clinical and angiographic efficacy of Coroflex Please with Taxus Liberte (Boston Scientific, Natick, MA) in a real-world practice. Methods and Results We performed a prospective, open-label, randomized, controlled study that enrolled 945 patients undergoing percutaneous coronary interventions in 18 centers in Korea. The primary end point was clinically driven target vessel revascularization at 9 months. The baseline characteristics were mostly similar and comparable between 2 groups. At 9 months, the incidence of clinically driven target vessel revascularization was 14.6% for Coroflex and 6.4% for Taxus, which was significantly different (hazard ratio 2.43, 95% CI 1.50-3.94, noninferiority P value = 1.000). This is well corroborated by the difference of in-stent late loss between 2 stents (0.71 +/- 0.64 mm vs 0.52 +/- 0.50 mm, P < .001) by 9-month follow-up angiography (n = 415 vs 215). Among secondary clinical end points, stent thrombosis (definite and probable) for 1 year was 2.2% in Coroflex and 1.3% in Taxus (P = .317). Also, myocardial infarction for 9 months was higher in Coroflex group than that in Taxus (4.9% vs 1.6%, P = .012), which was partly contributed by the higher incidence of periprocedural myocardial infarction in Coroflex arm (2.2% vs 0.3%, P = .028). Conclusions Coroflex Please was inferior to Taxus Liberte with regard to clinical and angiographic efficacy. (Am Heart J 2013;165:733-43.) | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MOSBY-ELSEVIER | - |
dc.title | Randomized trial comparing the efficacy between different types of paclitaxel-eluting stents: The comparison of Efficacy between COroflex PLEASe ANd Taxus stent (ECO-PLEASANT) randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ahj.2013.02.009 | - |
dc.identifier.bibliographicCitation | AMERICAN HEART JOURNAL, v.165, no.5, pp 733 - 743 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000318724000014 | - |
dc.identifier.scopusid | 2-s2.0-84876795847 | - |
dc.citation.endPage | 743 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 733 | - |
dc.citation.title | AMERICAN HEART JOURNAL | - |
dc.citation.volume | 165 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordPlus | CORONARY-ARTERY LESIONS | - |
dc.subject.keywordPlus | MUSCLE-CELL PROLIFERATION | - |
dc.subject.keywordPlus | ANGIOGRAPHIC FOLLOW-UP | - |
dc.subject.keywordPlus | CLINICAL-PRACTICE | - |
dc.subject.keywordPlus | DIABETIC-PATIENTS | - |
dc.subject.keywordPlus | STRUT THICKNESS | - |
dc.subject.keywordPlus | SLOW-RELEASE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | RESTENOSIS | - |
dc.subject.keywordPlus | REVASCULARIZATION | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.